Zelira Therapeutics (ZLDAF)
OTHER OTC:ZLDAF
Holding ZLDAF?
Track your performance easily

Zelira Therapeutics (ZLDAF) Technical Analysis

16 Followers

Summary of all the Indicators

Overall Consensus
Buy
13Bullish
1Neutral
8Bearish
Technical Analysis Consensus
Sell
3Bullish
1Neutral
6Bearish
Moving Average Consensus
Strong Buy
10Bullish
0Neutral
2Bearish
Zelira Therapeutics’s (ZLDAF) Moving Averages Convergence Divergence (MACD) indicator is <0.01, suggesting Zelira Therapeutics is a Sell.
Zelira Therapeutics’s (ZLDAF) 20-Day exponential moving average is 0.29, while Zelira Therapeutics’s (ZLDAF) share price is $0.552, making it a Buy.
Zelira Therapeutics’s (ZLDAF) 50-Day exponential moving average is 0.32, while Zelira Therapeutics’s (ZLDAF) share price is $0.552, making it a Buy.

Zelira Therapeutics (ZLDAF) Pivot Points

Nov 10, 2024, 07:57 AM
Name
S3
S2
S1
Pivot Points
R1
R2
R3
Classic
0.22
0.25
0.28
0.31
0.34
0.37
0.40
Fibonacci
0.25
0.27
0.29
0.31
0.33
0.35
0.37
Pivot points are a technical analysis tool used by traders to identify potential support and resistance levels in financial markets. Pivot points are calculated based on the previous day's high, low, and close prices, and are used to help traders identify levels at which the price may reverse or continue to trend.

Zelira Therapeutics (ZLDAF) Moving Averages

Nov 10, 2024, 07:57 AM
Period
Simple
Exponential
MA5
0.33Buy
0.35Buy
MA10
0.27Buy
0.30Buy
MA20
0.26Buy
0.29Buy
MA50
0.32Buy
0.32Buy
MA100
0.40Buy
0.39Buy
MA200
0.51Sell
0.51Sell
Zelira Therapeutics’s (ZLDAF) 10-Day exponential moving average is 0.30, while Zelira Therapeutics’s (ZLDAF) share price is $0.552, making it a Buy.
Zelira Therapeutics’s (ZLDAF) 100-Day exponential moving average is 0.39, while Zelira Therapeutics’s (ZLDAF) share price is $0.552, making it a Buy.
Zelira Therapeutics’s (ZLDAF) stock price is $0.552 and Zelira Therapeutics’s (ZLDAF) 50-day simple moving average is 0.32, creating a Buy signal.
Zelira Therapeutics’s (ZLDAF) stock price is $0.552 and Zelira Therapeutics’s (ZLDAF) 100-day simple moving average is 0.40, creating a Buy signal.
Zelira Therapeutics’s (ZLDAF) stock price is $0.552 and Zelira Therapeutics’s (ZLDAF) 200-day simple moving average is 0.51, creating a Sell signal.

Zelira Therapeutics (ZLDAF) Technical Indicators

Nov 10, 2024, 07:57 AM
Name
Value
Implied Action
RSI (14)
77.23
Sell
STOCH (9,6)
88.98
Sell
STOCHRSI (14)
89.03
Sell
MACD (12,26)
<0.01
Sell
ADX (14)
18.69
Buy
Williams %R
-1.22
Sell
CCI (14)
339.88
Sell
ATR (14)
0.06
-
Ultimate Oscillator
69.67
Neutral
ROC
92.00
Buy
Zelira Therapeutics’s (ZLDAF) Relative Strength Index (RSI) is 77.23, creating a Sell signal.
Zelira Therapeutics’s (ZLDAF) Trend Strength Indicator (ADX) is 18.69, creating a Buy signal.
Zelira Therapeutics’s (ZLDAF) Commodity Channel Index (CCI) is 339.88, creating a Sell signal.
Zelira Therapeutics’s (ZLDAF) Price Rate of Change (ROC) is 92.00, creating a Buy signal.

FAQ

Is ZLDAF a Buy, Hold, or Sell?
Based on ZLDAF’s technical indicators, ZLDAF is a Buy.
    What is ZLDAF’s RSI (14)?
    ZLDAF’s RSI (14) is 77.23, which suggests ZLDAF is a Sell.
      What is ZLDAF’s MACD?
      ZLDAF’s MACD is <0.01, which suggests ZLDAF is a Sell.
        What is ZLDAF’s 5-day moving average?
        ZLDAF’s 5-day moving average is 0.33, which suggests ZLDAF is a Buy.
          What is ZLDAF’s 20-day moving average?
          ZLDAF 20-day moving average is 0.26, which suggests ZLDAF is a Buy.
            What is ZLDAF’s 50-day moving average?
            ZLDAF’s 50-day moving average is 0.32, which suggests ZLDAF is a Buy.
              What is ZLDAF’s 200-day moving average?
              ZLDAF’s 200-day moving average is 0.51, which suggests ZLDAF is a Sell.
                What is ZLDAF’s Williams % R (14)?
                ZLDAF’s Williams % R (14) is -1.22, which suggests ZLDAF is a Sell.
                  What is ZLDAF’s CCI (14)?
                  ZLDAF’s CCI (14) is 339.88, which suggests ZLDAF is a Sell.
                    What am I Missing?
                    Make informed decisions based on Top Analysts' activity
                    Know what industry insiders are buying
                    Get actionable alerts from top Wall Street Analysts
                    Find out before anyone else which stock is going to shoot up
                    Get powerful stock screeners & detailed portfolio analysis